A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Academic Curriculum Components Bookmark and Share

Academic Curriculum Components

Clinical Cancer Genetics Course
All trainees in City of Hope’s Cancer Genetics Career Development Program (CGCDP) are required to complete this 16-week course. This course provides a comprehensive knowledge base in cancer genetics, including the following:
 
  • Carcinogenesis: cellular, molecular, genetic and environmental etiology
  • Clinical features, pathology, epidemiology and treatment of cancer
  • Hereditary cancer syndromes
  • Cancer risk assessment
  • Cancer genetic counseling skills development
  • Genetic testing: legal, ethical and insurance issues related to genetic testing
  • Role of cancer registries and clinical research trials
 
Curriculum materials are developed as a ten-day, 60-hour CME-accredited intensive course, which is also open to cancer risk counselors in underserved communities.

The course curriculum is updated periodically under the direction of the Advisory Committee to accommodate the rapid developments in cancer genetics knowledge. Faculty and trainees have the opportunity to deliver selected lectures and update course content.
 
Cancer Genetics Working Group
The CME-accredited Clinical Cancer Genetics Working Group is comprised of experts from various disciplines who discuss cases and the best care for each patient. The Working Group convenes weekly to:

Review all Cancer Screening & Prevention Program Network (CSPPN) patient and family case histories Discuss cancer risk assessment, genetic test results interpretation and management strategies Discuss case-related interpersonal and familial psychosocial issues, and candidacy for chemopreventive, epidemiological and behavioral research protocolsThe rich clinical experience, coupled with multidisciplinary case discussion, form the cornerstone of the program's experiential training.
 
Topics in Clinical Cancer Genetics
A weekly lecture series focuses on issues in clinical cancer genetics and cancer genetics research, alternating between didactic lectures and “journal club.” Participants comment on and interpret primary research reports on key topics in molecular cancer genetics, risk assessment, epidemiological and behavioral research, and clinical cancer prevention. They learn how to present findings in summary form and incorporate important research findings into clinical practice and research projects. This lecture series is a primary forum for updates. A list of these topics and attachments to the related articles are also posted on our WebBoard, “The Genetics Link.”

The Genetics Link is City of Hope’s Clinical Cancer Genetics web forum. To expand their practical knowledge in the field of clinical cancer genetics, members of this discussion group exchange ideas and receive valuable feedback from experts and from one another. Membership in The Genetics Link is open by invitation only and to those who have been part of the Clinical Cancer Genetics Technology Transfer Research (CCGTTR) courses and outreach activities.
 
In collaboration with Dr. Stanley Azen, Director of the USC Graduate Programs in Biometry and Epidemiology, a dual-track customized curriculum in cancer epidemiology was initiated with University of Southern California (USC). The curriculum consists of two modules, in which trainees enroll concurrently.
 
All trainees are required to participate in selected topics.

 

 

Academic Curriculum Components

Academic Curriculum Components

Clinical Cancer Genetics Course
All trainees in City of Hope’s Cancer Genetics Career Development Program (CGCDP) are required to complete this 16-week course. This course provides a comprehensive knowledge base in cancer genetics, including the following:
 
  • Carcinogenesis: cellular, molecular, genetic and environmental etiology
  • Clinical features, pathology, epidemiology and treatment of cancer
  • Hereditary cancer syndromes
  • Cancer risk assessment
  • Cancer genetic counseling skills development
  • Genetic testing: legal, ethical and insurance issues related to genetic testing
  • Role of cancer registries and clinical research trials
 
Curriculum materials are developed as a ten-day, 60-hour CME-accredited intensive course, which is also open to cancer risk counselors in underserved communities.

The course curriculum is updated periodically under the direction of the Advisory Committee to accommodate the rapid developments in cancer genetics knowledge. Faculty and trainees have the opportunity to deliver selected lectures and update course content.
 
Cancer Genetics Working Group
The CME-accredited Clinical Cancer Genetics Working Group is comprised of experts from various disciplines who discuss cases and the best care for each patient. The Working Group convenes weekly to:

Review all Cancer Screening & Prevention Program Network (CSPPN) patient and family case histories Discuss cancer risk assessment, genetic test results interpretation and management strategies Discuss case-related interpersonal and familial psychosocial issues, and candidacy for chemopreventive, epidemiological and behavioral research protocolsThe rich clinical experience, coupled with multidisciplinary case discussion, form the cornerstone of the program's experiential training.
 
Topics in Clinical Cancer Genetics
A weekly lecture series focuses on issues in clinical cancer genetics and cancer genetics research, alternating between didactic lectures and “journal club.” Participants comment on and interpret primary research reports on key topics in molecular cancer genetics, risk assessment, epidemiological and behavioral research, and clinical cancer prevention. They learn how to present findings in summary form and incorporate important research findings into clinical practice and research projects. This lecture series is a primary forum for updates. A list of these topics and attachments to the related articles are also posted on our WebBoard, “The Genetics Link.”

The Genetics Link is City of Hope’s Clinical Cancer Genetics web forum. To expand their practical knowledge in the field of clinical cancer genetics, members of this discussion group exchange ideas and receive valuable feedback from experts and from one another. Membership in The Genetics Link is open by invitation only and to those who have been part of the Clinical Cancer Genetics Technology Transfer Research (CCGTTR) courses and outreach activities.
 
In collaboration with Dr. Stanley Azen, Director of the USC Graduate Programs in Biometry and Epidemiology, a dual-track customized curriculum in cancer epidemiology was initiated with University of Southern California (USC). The curriculum consists of two modules, in which trainees enroll concurrently.
 
All trainees are required to participate in selected topics.

 

 
Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 


NEWS & UPDATES
  • Are you thinking about switching from traditional cigarettes to e-cigarettes for the Great American Smokeout? Are you thinking that might be a better option than the traditional quit-smoking route? Think again. For lung expert Brian Tiep, M.D., the dislike and distrust he feels for e-cigs comes down to this: Th...
  • Hematologist Robert Chen, M.D., is boosting scientific discovery at City of Hope and, by extension, across the nation. Just ask the National Cancer Institute. The institution recently awarded Chen the much-sought-after Clinical Investigator Team Leadership Award for boosting scientific discovery at City of Hope...
  • Great strides have been made in treating cancer – including lung cancer – but by the time people show symptoms of the disease, the cancer has usually advanced. That’s because, at early stages, lung cancer has no symptoms. Only recently has lung cancer screening become an option. (Read more about the risks...
  • Identifying cures for currently incurable diseases and providing patients with safe, fast and potentially lifesaving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I). The clinic is funded by an $8 million, five-year grant from the California Institute for Regene...
  • Cancer is a couple’s disease. It affects not just the person diagnosed, but his or her partner as well. It also affects the ability of both people to communicate effectively. The Couples Coping with Cancer Together program at City of Hope teaches couples how to communicate and solve problems as a unit. He...
  • Chemotherapy drugs work by either killing cancer cells or by stopping them from multiplying, that is, dividing. Some of the more powerful drugs used to treat cancer do their job by interfering with the cancer cells’ DNA and RNA growth, preventing them from copying themselves and dividing. Such drugs, however, l...
  • During October, everything seems to turn pink – clothing, the NFL logo, tape dispensers, boxing gloves, blenders, soup cans, you name it – in order to raise awareness for what many believe is the most dangerous cancer that affects women: breast cancer. But, in addition to thinking pink, women should...
  • In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. The pneumonia complicated what was already destined to be grueling treatment regimen. To assess the extent of her illness, Maya had to endure a spinal ...
  • Former smokers age 55 to 74 who rely on Medicare for health care services have just received a long-hoped-for announcement. Under a proposed decision from the Centers for Medicare and Medicaid Services, they’ll now have access to lung cancer screening with a low-dose CT scan. The proposed decision, announ...
  • City of Hope has a longstanding commitment to combating diabetes, a leading national and global health threat. Already, it’s scored some successes, from research that led to the development of synthetic human insulin – still used by millions of patients – to potentially lifesaving islet cell transplants. Diabet...
  • Dee Hunt never smoked. Neither did her five sisters and brothers. They didn’t have exposure to radon or asbestos, either. That didn’t prevent every one of them from being diagnosed with lung cancer. Their parents were smokers, but they’d all left home more than 30 years before any of them were diagn...
  • They may not talk about it, but women with cancers in the pelvic region, such as cervical cancer, bladder cancer and uterine cancer, often have problems controlling their urine, bowel or flatus. Although they may feel isolated, they’re far from alone. Many other women have such problems, too. In fact, nea...
  • Cancer that spreads to the liver poses a significant threat to patients, and a great challenge to surgeons. The organ’s anatomical complexity and its maze of blood vessels make removal of tumors difficult, even for specialized liver cancer surgeons. Following chemotherapy, the livers of cancer patients are not ...
  • A new study suggests that the colorectal cancer outlook is more grim than many thought, with the number of cases among young adults actually rising. But the study, which made headlines around the country, might not have the obvious message many consumers think. Donald David, M.D., chief of gastroenterology at C...
  • Patients faced with a cancer diagnosis have a lot to take in. It’s no surprise that many need help airing their concerns to their care teams. That’s why a City of Hope team developed SupportScreen, to enable patients to communicate their needs better. Last week, the tablet-based app hit an important milestone, ...